This is ready to rally....More positive comments from Credit Suisse
tal Data in
cell and T
Efficacy remains robust with a 68% overall response rate in indolent NHL, 67% response
rate in MCL, and 33% response rate in T
Neutropenia is seen in the lymphoma patients, but not as much as in the CL
which likely reflects the disease state and the patients enrolled.
Elevated liver enzymes, however, were more common in the lymphoma patients, which is
an observation that has been seen with this class of drug.